BiomarkersHumans
Exploratory Semi‐Supervised Clustering to Identify Dementia and MCI Cohorts with a Brief Automated Digital Assessment Protocol
AAIC 2025 Abstract
Abstract
Background: The Apheleia‐001 study deployed a panel of digital and blood‐based biomarkers designed to reduce the screen failure rate among participants interested in therapeutic clinical trials for Alzheimer's disease.